Thyroid Disease Perspective

 
 

  • Mechanisms of Hypothalamic Inflammation in Obesity Dr Adam Gilden explores the challenges in managing hypothalamic obesity, and a multidisciplinary approach to address the specific needs of individuals affected by this multifaceted condition.
  • How to Prescribe Zepbound Recently approved tirzepatide joins semaglutide as an option for patients with obesity. Beverly Tchang, MD, offers her recommendations based on her experience for prescribing.
  • Can Endos Use Social Media Safely?   In this episode of the Thyroid Stimulating Podcast, Kaniksha Desia, MD, interviews Malini Gupta, MD, about her use of social media and best practices for endocrinologists.
  • An Update on Lipoprotein(a): The Latest on Testing, Treatment, and Guideline Recommendations This review highlights the current state of Lipoprotein(a), including updates from clinical trial outcomes and guideline recommendations supporting once-in-a-lifetime measurement in most individuals with increased risk of atherosclerotic CVD.
  • When to Order Antinuclear Antibodies in Primary Care   Tips from an expert rheumatologist also reveal when not to order ANA and how to interpret the results.
  • Illustrating the Progression of Thyroid Eye Disease   Thyroid Eye Disease often causes quality-of-life changes for patients. Endocrinologist Malini Gupta, MD, demonstrates the structural changes of thyroid eye disease in this series of images.
  • Managing Dyslipidemia in 50-Year-Old Man With Hypothyroidism A 50-year-old man with primary hypothyroidism is referred by his primary care physician to a cardiologist for evaluation of high low-density lipoprotein cholesterol. How would you manage his case?
  • When to Prescribe Semaglutide? Semaglutide produces significant weight loss in most people with obesity. When should it be prescribed, and what are the pitfalls?
  • ATA 2023 Read clinically focused news coverage of key developments from ATA 2023
  • Hormone Replacement Therapy for Postmenopausal Osteoporosis Postmenopausal women are at increased risk for fractures. Hormone replacement therapy, particularly estrogen, can be beneficial.
  • Journal Summary: Vitiligo Journal Summaries provide a quick review of recent journal articles with current or near-term clinical significance. Catch up on key research on vitiligo from the past year.
  • Diet and Brain: From Processed Foods to the Farmers Market   Kathrin LaFaver interviews fellow neurologist Madhureeta Achari on the nutritional deficiencies she checks for and why she invites her patients to the farmers market.
  • Testing Kids for Celiac Disease: Who, When, How   The Cribsiders talk about having a low threshold for testing a child for celiac disease, and which tests to order first.
  • My Favorite Iron Pearls A 45-year-old women presents for evaluation of fatigue. She has been tired for the past 6 months. What would you recommend?
  • Thyroid Cancer Survivorship: A Physician's Own Experience   Kaniksha Desai, MD, interviews Anupam Kotwal, MD, about his journey from doctor to patient and how he managed his thyroid cancer diagnosis.
  • Episode 5: Health Disparities in Advanced and Metastatic Breast Cancer   Drs Banu Arun and Stephanie Graff discuss drug access, clinical trials, and health disparities in advanced and metastatic breast cancer, and inclusion-based solutions for physicians and institutions.
  • Episode 1: Immunotherapy in TNBC: What's New, What's Next?   Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic.
  • Preventing 'Worm-eaten Bones' From Hyperthyroidism Bone loss is often associated with hyperthyroidism; can it be reversed, and if so, how?
  • Dead-Donor Parathyroid Tissue Cures Hypoparathyroidism Surgeons in Canada recently cured a patient of severe hypoparathyroidism with parathyroid tissue transplanted from a deceased donor.
  • Time to End Direct-to-Consumer Ads, Says Physician A physician feels that prescription drug recommendations should come from doctors, and that consumers can't necessarily evaluate the usefulness of drugs they see advertised.